Abstract Terminal deoxynucleotidyl transferase (TdT) is overexpressed in some cancer types, where it drives the mutagenic repair of double strand breaks through non canonical non-homologous end joining pathway. The TdT enzyme belongs to the X family of polymerases, together with the DNA polymerase λ (pol λ) and β (pol β). However, TdT exclusively displays template-independent nucleotide polymerisation. Pursuing our studies in developing TdT inhibitors, herein we deepened the structure-activity relationships of new structural analogues of our previously identified hit compounds. The diketo hexenoic acid derivatives here analysed showed high selectivity towards TdT and inhibition potencies spanning from the low micromolar range to the nanomolar. Docking studies highlighted the chemical features involved in the TdT binding, well contributing to the rationalisation of the structural requirements needed for the enzymatic inhibition. Graphical Abstract
Exploring structure–activity relationships of pyrrolyl diketo acid derivatives as non-nucleoside inhibitors of terminal deoxynucleotidyl transferase enzyme
V. N. Madia,Nadia Garibaldi,Davide Ialongo,E. Patacchini,Valeria Tudino,Giuseppe Ruggieri,Laura Zarbo,Emanuele Cara,Antonio Coluccia,M. Artico,L. Scipione,A. Messore,Francesco Saccoliti,Elisa Mentegari,Giovanni Maga,R. Di Santo,E. Crespan,R. Costi
Published 2025 in Journal of Enzyme Inhibition and Medicinal Chemistry
ABSTRACT
PUBLICATION RECORD
- Publication year
2025
- Venue
Journal of Enzyme Inhibition and Medicinal Chemistry
- Publication date
2025-06-09
- Fields of study
Medicine, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-49 of 49 references · Page 1 of 1
CITED BY
- No citing papers are available for this paper.
Showing 0-0 of 0 citing papers · Page 1 of 1